Age-related macular degeneration, often abbreviated as AMD, is one of the leading causes of vision loss among older adults worldwide. In Asia, where populations are ageing rapidly, its impact is particularly profound. For many, the disease quietly erodes central vision, making everyday activities such as reading, driving, and recognising faces increasingly difficult. Against this backdrop, the Translational Asian Age-related Macular Degeneration Programme, or TAAP for short, has emerged as a bold and ambitious effort to confront the disease head-on. Now in its second phase, TAAP-2 represents a significant evolution in both scientific scope and clinical ambition.

Light is something we encounter every day, so familiar that it rarely inspires a second thought. Yet beneath its apparent simplicity lies a remarkable complexity. Light can carry information in its brightness and color, but also in its polarization and phase, subtle properties that describe how its waves oscillate and interact. For decades, these hidden dimensions of light have remained largely untapped in medicine. Now, a growing body of research is beginning to reveal their extraordinary potential.

At first glance, hydroponic farming seems like the future made real. Rows of leafy greens grow indoors, roots suspended in carefully balanced nutrient solutions, untouched by soil and shielded from many of the uncertainties of outdoor agriculture. This method promises efficiency, precision, and sustainability. It uses far less water than traditional farming and produces food in tightly controlled environments. Yet beneath this clean and modern image lies a quieter story about risk, one that flows through the very water that sustains these crops.